Navigation Links
By adding VSL#3 probiotic to traditional therapies UC patients can improve remission rates
Date:6/7/2012

GAITHERSBURG, MD, June 7 As one of the few probiotics with medical food designation for specific illnesses, VSL#3 has been the subject of a collection of more than 80 studies that have demonstrated its use in the dietary management of IBS, ulcerative colitis, and an ileal pouch. Ulcerative colitis patients, in particular, have been shown to benefit from adding VSL#3 medical food to their prescription drug regimen. One particular study shows that the combination of VSL#3 and traditional drug therapy can improve remission rates over drug therapy alone by 10 to 17 percent, and can initiate remission 47 to 69 percent faster. The 8-week study*, conducted in Rome, involved 90 patients who had newly diagnosed or recently relapsed mild-to-moderate UC and compared the effects of the combination of VSL#3 and balsalazine (Colazal), an anti-inflammatory drug commonly prescribed for the treatment of ulcerative colitis, to the use of balsalazine alone and mesalazine (Canasa) alone.

The trial results concluded that the use of low-dose balsalazide and VSL#3 was significantly superior (p<0.02) in obtaining remission than just the use of balsalazide alone (10 percent improvement) and mesalazine alone (17 percent improvement). The VSL#3/balsalazine combination also initiated remission faster than the drug therapy alone with an average of 4 days versus 7.5 days (balsalazide only) and 13 days (mesalazine only). The improvement of well-being and reduction in bowel frequency was significant as well1.

"Many UC patients try a variety of methods in order to extend their time between flare-ups and obtain remission," said Mary Berry, senior product manager at Sigma-Tau Pharmaceuticals, Inc., maker of VSL#3. "By having a personalized regimen with a drug, such as balsalazide, and adding VSL#3 for their dietary management, patients can see a positive and quick remission that will work for them."

Ulcerative colitis is a chronic disease that causes inflammation
'/>"/>

Contact: Nicole Egan
negan@rlapr.com
914-241-0086 x28
Robin Leedy & Associates, Inc.
Source:Eurekalert

Page: 1 2

Related biology news :

1. Invisible helpers: How probiotic bacteria protect against inflammatory bowel diseases
2. Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment
3. Some improved cookstoves may emit more pollution than traditional mud cookstoves
4. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
5. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
6. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
7. Cardio fitness levels of breast cancer patients may affect survival
8. Modest alcohol intake associated with less inflammation in patients with common liver disease
9. Increased fructose consumption may deplete cellular energy in patients with obesity and diabetes
10. New data suggests interferon-free therapy around the corner for HCV patients
11. Drug interactions wont exclude HCV transplant or HIV co-infected patients from treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (June, 2014) Outstanding basic research, a growing ... dedication to patient care have earned the Herbert ... Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 ... National Cancer Institute (NCI). The grant renews the ... Comprehensive Cancer Centers in New York City and ...
(Date:8/27/2014)... factors thought to be associated with outcomes after ... age of the patient, mechanism of injury, nerve ... method, operation technique, and repair materials. However, despite ... peripheral nerve injuries, there is no agreement regarding ... the dose-effect relationship of the predictors has not ...
(Date:8/27/2014)... research finds , Gamblers show the same tendencies ... has shown. , Researchers, led by Dr Elliot Ludvig ... tests that found that both human gamblers and pigeons ... low-value rewards. , Published in Biology Letters , ... important role that memories of previous biggest wins and ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Gamblers are greedy bird-brains, University of Warwick research finds 2
... the body's motor nerve cells grow along proper paths ... inhibiting spinal-cord neurons from regenerating after injury, researchers at ... the researchers found that a component of myelin ?a ... in adult vertebrates ?chemically blocks the ability of nerve ...
... for the first time that bacteria, in addition to ... sparkling wine known as Cava. They report their findings ... Society for Microbiology. , "Bacteria found in Cava samples ... in terms of aroma, flavor, bubble size and bubble ...
... hanging basket style device is at the heart of a plan ... sex drive of a major pest of fruit ... that very same pest. The device allows growers to selectively ... killing other beneficial insects. , The researchers at Warwick HRI, the ...
Cached Biology News:Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3After the yeast is gone bacteria continue to develop flavor of sparkling wine 2Hanging baskets of sex and death help fruit growers 2
(Date:8/27/2014)... -- Lisa Kulik saw fireworks for the first time in ... a groundbreaking retinal implant co-invented by Mark Humayun ... University of Southern California (USC) Eye Institute. ... resident who has retinitis pigmentosa, a degenerative disease ... 2, she became the first person west of the ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com has ... The Graphene Opportunity - A Rational View ... The New Nanotech? A similar amount of ... applications ranging from microelectronics to water treatment, but ... the availability of the Graphene Opportunity Report, authored ...
(Date:8/27/2014)... 2014  ARCH Venture Partners, one of the ... development of seed and early-stage advanced technology companies, ... with more than $400 million in subscriptions. ARCH ... target by more than $150 million. ... and potential of our approach to finding and ...
(Date:8/27/2014)... 2014 After the boom of the ... next beverage craze is going to be the stress ... can use Stress Relief energy pattern which can be ... of a beverage, including minerals, herbs and liquids. Stress ... that power into rapid recovery and helping to adapt ...
Breaking Biology Technology:USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 2USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 3USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 4USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 5The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4
... 28 N30 Pharma (N30), a,biopharmaceutical company focused ... regulate nitric oxide bioavailability,announced today that it has ... N30 will use proceeds from this financing ... expand its discovery and preclinical,research in the area ...
... Be Webcast Live On Company,s Website -, TUSTIN, ... ), a clinical stage biopharmaceutical,company developing monoclonal antibodies for ... that senior management will,present at the BIO Investor Forum ... (6:45 pm EDT). The conference will be held at ...
... ITMN ) announced today that it will release ... at 4:00 p.m. Eastern time.,A live conference call and ... time that same day., To access the live ... To access the,webcast, please log on to the company,s ...
Cached Biology Technology:N30 Pharma Announces Financing, Expansion of Board 2Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2InterMune to Release Third Quarter 2008 Financial Results on November 6 2